Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?
Key PointsNovo Nordisk has lost its lead in the weight loss market.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.